Investigation of Safety/Tolerability, Pharmacokinetics and Pharmacodynamics After Multiple Ascending Doses of BYK324677 in Healthy Volunteers. A Monocentre, Placebo-controlled, Cross-over, Double-blind, Randomised Trial
Phase of Trial: Phase I
Latest Information Update: 11 Aug 2013
At a glance
- Drugs BYK 324677 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 29 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Nov 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 05 Jul 2011 New trial record